Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 73.17
-1.28 (-1.72%)
Apr 29, 2026, 3:00 PM CST
SHA:688336 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 2,974 | 2,899 | 704.58 | 294.61 | 49.3 | 18.06 | Upgrade
|
| Depreciation & Amortization | 123.47 | 123.47 | 127.97 | 96.08 | 122.41 | 135.46 | Upgrade
|
| Other Amortization | 0.36 | 0.36 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.09 | 1.09 | -0.12 | -56.39 | 0.94 | 12.98 | Upgrade
|
| Loss (Gain) From Sale of Investments | -99.77 | -99.77 | -411.59 | -3 | -19.98 | -20.93 | Upgrade
|
| Stock-Based Compensation | 26.46 | 26.46 | 6.97 | -6.28 | 2.54 | 11.42 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.26 | -0.26 | -0.23 | -6.79 | 5.49 | 1.22 | Upgrade
|
| Other Operating Activities | -401.87 | -74.03 | -77.49 | -35.91 | 3.68 | -20.61 | Upgrade
|
| Change in Accounts Receivable | 23.78 | 23.78 | -60.93 | 15.4 | 107.1 | -258.94 | Upgrade
|
| Change in Inventory | -30.46 | -30.46 | -35.01 | 33.36 | - | - | Upgrade
|
| Change in Accounts Payable | 186.34 | 186.34 | 17.83 | 63.46 | 9.24 | -67.49 | Upgrade
|
| Change in Unearned Revenue | -15.64 | -15.64 | -7.09 | -5.46 | -10.49 | -18.83 | Upgrade
|
| Operating Cash Flow | 2,791 | 3,043 | 281.14 | 416.35 | 233.49 | -243.79 | Upgrade
|
| Operating Cash Flow Growth | 899.80% | 982.55% | -32.48% | 78.32% | - | - | Upgrade
|
| Capital Expenditures | -263.32 | -252.95 | -280.78 | -235.75 | -221.26 | -263.82 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.69 | 100.45 | 0.4 | 0.38 | Upgrade
|
| Investment in Securities | -2,866 | -3,058 | -953.98 | -366.5 | -725.89 | 214 | Upgrade
|
| Other Investing Activities | 207.32 | 147.07 | 483.93 | 22.37 | 30.06 | 30.94 | Upgrade
|
| Investing Cash Flow | -2,922 | -3,164 | -750.14 | -479.42 | -916.69 | -18.5 | Upgrade
|
| Short-Term Debt Issued | - | - | 50 | 50 | 150 | - | Upgrade
|
| Total Debt Issued | - | - | 50 | 50 | 150 | - | Upgrade
|
| Short-Term Debt Repaid | - | -50 | -50 | -150 | - | - | Upgrade
|
| Total Debt Repaid | -50 | -50 | -50 | -150 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -50 | -50 | - | -100 | 150 | - | Upgrade
|
| Issuance of Common Stock | 15.39 | 15.39 | - | - | 2.3 | - | Upgrade
|
| Common Dividends Paid | -76.17 | -76.46 | -52.37 | -1.47 | -1.22 | - | Upgrade
|
| Financing Cash Flow | -110.78 | -111.07 | -52.37 | -101.47 | 151.08 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.2 | 4.67 | 0.28 | 2.27 | 1.47 | -0.17 | Upgrade
|
| Net Cash Flow | -238.47 | -226.53 | -521.1 | -162.27 | -530.66 | -262.47 | Upgrade
|
| Free Cash Flow | 2,527 | 2,791 | 0.35 | 180.61 | 12.23 | -507.61 | Upgrade
|
| Free Cash Flow Growth | 16578.80% | 787511.40% | -99.80% | 1376.67% | - | - | Upgrade
|
| Free Cash Flow Margin | 58.52% | 66.45% | 0.03% | 17.81% | 1.48% | -54.65% | Upgrade
|
| Free Cash Flow Per Share | 4.07 | 4.50 | 0.00 | 0.29 | 0.02 | -0.84 | Upgrade
|
| Cash Income Tax Paid | 212.58 | 44.26 | 43.1 | 29.24 | 24.57 | 21.75 | Upgrade
|
| Levered Free Cash Flow | -1,378 | 1,979 | -66.63 | 46.51 | -14.48 | -394.76 | Upgrade
|
| Unlevered Free Cash Flow | -1,377 | 1,979 | -65.9 | 47.38 | -13.66 | -394.76 | Upgrade
|
| Change in Working Capital | 166.83 | 166.83 | -68.94 | 134.03 | 69.1 | -381.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.